537253 SUNLOC

Sunil Healthcare Share Price

 

 

Start SIP in SUNLOC

Start SIP

Performance

  • Low
  • ₹68
  • High
  • ₹72
  • 52 Week Low
  • ₹61
  • 52 Week High
  • ₹89
  • Open Price₹70
  • Previous Close₹68
  • Volume106
  • 50 DMA₹71.63
  • 100 DMA₹73.40
  • 200 DMA₹75.07

Investment Returns

  • Over 1 Month + 5.98%
  • Over 3 Month -3.64%
  • Over 6 Month -14.96%
  • Over 1 Year -7.69%

Smart Investing Starts Here Start SIP with Sunil Healthcare for Steady Growth!

Invest Now

Sunil Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 42.7
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 74
  • P/B Ratio
  • 1.1
  • Average True Range
  • 3.98
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.08
  • RSI
  • 52.53
  • MFI
  • 43.81

Sunil Healthcare Financials

Sunil Healthcare Technicals

EMA & SMA

Current Price
₹72.00
+ 4.32 (6.38%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹70.78
  • 50 Day
  • ₹71.63
  • 100 Day
  • ₹73.40
  • 200 Day
  • ₹75.07

Resistance and Support

70.67 Pivot Speed
  • R3 77.33
  • R2 74.67
  • R1 73.33
  • S1 69.33
  • S2 66.67
  • S3 65.33

Sunil Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-04 Quarterly Results
2025-07-30 Quarterly Results
2025-05-29 Audited Results
2025-02-13 Quarterly Results
2024-11-13 Quarterly Results

Sunil Healthcare F&O

Sunil Healthcare Shareholding Pattern

73.53%
0.1%
17.85%
8.52%

Sunil Healthcare FAQs

Sunil Healthcare share price is ₹72 As on 19 January, 2026 | 07:50

The Market Cap of Sunil Healthcare is ₹73.8 Cr As on 19 January, 2026 | 07:50

The P/E ratio of Sunil Healthcare is 42.7 As on 19 January, 2026 | 07:50

The PB ratio of Sunil Healthcare is 1.1 As on 19 January, 2026 | 07:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23